A recent study using human hepatoma HepaRG cells found that NGN suppressed the activity of oncogenic metabolism through the regulation of miRNA-targeted mRNA expression inhibiting PI3K–Akt signaling [62]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.